- Home
- LIXT vs CNEY Comparison
LIXT vs CNEY Comparison
Compare LIXT & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- CNEY
- Stock Information
- Founded
- LIXT 2005
- CNEY 2018
- Country
- LIXT United States
- CNEY China
- Employees
- LIXT N/A
- CNEY N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- CNEY Major Chemicals
- Sector
- LIXT Health Care
- CNEY Industrials
- Exchange
- LIXT Nasdaq
- CNEY Nasdaq
- Market Cap
- LIXT 2.2M
- CNEY 2.1M
- IPO Year
- LIXT N/A
- CNEY 2021
- Fundamental
- Price
- LIXT $4.00
- CNEY $2.58
- Analyst Decision
- LIXT
- CNEY
- Analyst Count
- LIXT 0
- CNEY 0
- Target Price
- LIXT N/A
- CNEY N/A
- AVG Volume (30 Days)
- LIXT 6.2M
- CNEY 43.1K
- Earning Date
- LIXT 08-07-2025
- CNEY 01-01-0001
- Dividend Yield
- LIXT N/A
- CNEY N/A
- EPS Growth
- LIXT N/A
- CNEY N/A
- EPS
- LIXT N/A
- CNEY N/A
- Revenue
- LIXT N/A
- CNEY $50,957,974.00
- Revenue This Year
- LIXT N/A
- CNEY N/A
- Revenue Next Year
- LIXT N/A
- CNEY N/A
- P/E Ratio
- LIXT N/A
- CNEY N/A
- Revenue Growth
- LIXT N/A
- CNEY N/A
- 52 Week Low
- LIXT $0.64
- CNEY $2.53
- 52 Week High
- LIXT $4.45
- CNEY $40.00
- Technical
- Relative Strength Index (RSI)
- LIXT 80.89
- CNEY 38.58
- Support Level
- LIXT $2.02
- CNEY $2.59
- Resistance Level
- LIXT $4.25
- CNEY $2.84
- Average True Range (ATR)
- LIXT 0.54
- CNEY 0.11
- MACD
- LIXT 0.30
- CNEY 0.01
- Stochastic Oscillator
- LIXT 96.99
- CNEY 10.68
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.